Cargando…

PB2188: APPLICATION PROSPECT OF LOW DOSE PORCINE ANTITHYMOCYTE GLOBULIN IN HLA MATCHED SIBLING DONOR TRANSPLANTATION

Detalles Bibliográficos
Autores principales:	chen, X., zhang, R., zhai, W., ma, Q., pang, A., yang, D., he, Y., wei, J., feng, S., han, M., Jiang, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431410/ http://dx.doi.org/10.1097/01.HS9.0000851580.41287.4e

Ejemplares similares

PB2177: ANTITHYMOCYTE GLOBULIN AS TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE - 10 YEARS OF EXPERIENCE AT A SINGLE-CENTER
por: Dantas Rodrigues, C., et al.
Publicado: (2022)

PB2188: PROTON PUMP INHIBITORS ARE SAFE AND EFFECTIVE IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA TREATED WITH LOW-DOSE ASPIRIN
por: Krecak, Ivan, et al.
Publicado: (2023)

Role of antithymocyte globulin in matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies
por: Dou, Liping, et al.
Publicado: (2021)

Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants
por: Wang, Hong, et al.
Publicado: (2017)

A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation
por: Lee, Myung-Won, et al.
Publicado: (2020)

PB2629: LATE DIAGNOSIS OF TWO ADULT SIBLINGS WITH BERNARD SOULIER SYNDROME (BSS)
por: Altowyan, Essam, et al.
Publicado: (2023)

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis
por: Robin, Marie, et al.
Publicado: (2019)

PB2288: THE ABO SYSTEM POLYMORPHISM IN ALGERIAN BLOOD DONORS
por: talbi, F., et al.
Publicado: (2022)

PB2198: EFFECTS OF NOVEL CORONAVIRUS VACCINATION ON THE COLLECTION OF PERIPHERAL BLOOD HEMATOPOIETIC STEM CELLS FROM HEALTHY DONORS
por: Wang, Z., et al.
Publicado: (2022)

PB2567: THE EFFECT OF BLOOD DONATIONS ON IRON DEFICIENCY IN BLOOD DONORS
por: Lastochkina, Daria, et al.
Publicado: (2023)

PB2243: TREATMENT OF TWO JORDANIAN SIBLINGS WITH CONGENITAL DYSERYTHROPOEITIC ANEMIA - TYPE 1BUSING INTERFERON-ALPHA-2A
por: Khattab, E., et al.
Publicado: (2022)

Antithymocyte Globulin: Indiscriminate Use and Complications
por: Khan, Taqi, et al.
Publicado: (2019)

PB2203: AGEING OF LONG-TERM ALLOGENEIC HEMATOPOIETIC CELLS RECIPIENTS COMPARED TO THEIR DONORS
por: Czarnogórski, M., et al.
Publicado: (2022)

PB1752: ANALYSIS OF HLA-PEPTIDE BINDING POCKETS IN PATIENTS WITH ACUTE LEUKEMIA UNDERGOING UMBILICAL CORD BLOOD TRANSPLANTATION
por: Boukouaci, W., et al.
Publicado: (2022)

Reactivation of Hemophagocytic Lymphohistiocytosis Triggered by Antithymocyte Globulin
por: Matsuda, Kensuke, et al.
Publicado: (2017)

PB2190: HLA-HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE AFTER REDUCED-INTENSITY CONDITIONING
por: Kim, J., et al.
Publicado: (2022)

Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
por: Singh, Namita, et al.
Publicado: (2018)

PB1972: PAEONIFLORIN ALLEVIATES BIPN BY REDUCING IL6 LEVELS AND MODULATING PARKIN-MEDIATED MITOPHAGY
por: Sun, R., et al.
Publicado: (2022)

PB2277: ANALYSIS ON POLLUTION STATUS AND INFLUENCING FACTORS OF NURSES’ UNIFORMS IN HEMATOLOGY GENERAL WARD
por: Du, X., et al.
Publicado: (2022)

PB2418: CLINICAL FEATURES AND PROGNOSIS OF ADENOVIRUS INFECTION AFTER HAPLOIDENTICAL DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Sun, Wei, et al.
Publicado: (2023)

P1364: HLA MISMATCHED UNRELATED STEM CELL TRANSPLANTATION USING ANTITHYMOCYTE GLOBULIN IS A SUITABLE ALTERNATIVE FOR PATIENTS LACKING HLA-MATCHED UNRELATED DONORS: SINGLE CENTER LONG-TERM FOLLOW-UP DATA ANAL
por: Wang, L., et al.
Publicado: (2022)

PB2311: LOW-DOSE PREDNISON AND ELTROMBOPAG COMBINATION AS FRONTLINE TREATMENT IN NEWLY DIAGNOSED ITP PATIENTS
por: Liu, S.-Y., et al.
Publicado: (2022)

Retrospective Comparison of Efficacy and Safety of Rabbit Anti-Thymocyte Globulin and Porcine Anti-Lymphocyte Globulin in Patients With Acquired Aplastic Anemia Undergoing Hematopoietic Stem Cell Transplantation From Matched Sibling Donors
por: Zhang, Yuanfeng, et al.
Publicado: (2022)

PB2046: SHORT-TERM EFFICACY OF DECITABINE IN COMBINATION WITH LOW-DOSE CHEMOTHERAPY IN THE TREATMENT OF JMML: A RETROSPECTIVE STUDY
por: Cai, Y., et al.
Publicado: (2022)

PB2315: EFFICACY AND SAFETY OF TWO DIFFERENT LOW-DOSE RITUXIMAB REGIMENS FOR CHINESE CHILDREN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA
por: Zhu, X.
Publicado: (2022)

PB2434: DONOR CELL INDUCING IMMUNE-TOLERANCE IMPROVED ENGRAFTMENT IN TΑΒ+ CELL DEPLETED HSCT IN PATIENTS WITH THALASSEMIA MAJOR
por: Liao, Jianyun, et al.
Publicado: (2023)

PB1765: EFFICACY OF A NEW INDUCTION REGIMEN IN THE TREATMENT OF EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA.
por: Wang, M., et al.
Publicado: (2022)

PB2325: APPLICATION AND COMPARISON OF TWO PHARMACOKINETIC DETECTION METHODS IN CHILDREN WITH HEMOPHILIA A—AN INSPECTION REPORT FROM SINGLE CENTER
por: Li, C.-G., et al.
Publicado: (2022)

PB2005: BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: A REAL-WORLD STUDY OF CHINA
por: Jingyu, X., et al.
Publicado: (2022)

PB2290: SEROPREVALENCE OF HEPATITIS B AND C VIRUSES, HIV-1/2 AND SYPHILIS AMONG BLOOD DONORS IN THE CENTRE REGION OF ALGERIA
por: talbi, F., et al.
Publicado: (2022)

Rabbit Antithymocyte Globulin Causes Blastomyces and Histoplasma Antigenemia
por: Kaur, Amrit, et al.
Publicado: (2019)

PB2033: INFLUENCE OF INDUCTION THERAPY WITH LENALIDOMIDE ON MAINTENANCE THERAPY AND PROGNOSIS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
por: Sun, Q., et al.
Publicado: (2022)

PB2108: PREVALENCE AND CLINICAL IMPLICATIONS OF CYCLIN D1 POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA
por: Liang, X., et al.
Publicado: (2022)

PB2408: PREVALENCE OF METABOLIC SYNDROME IN LONG TERM HEMATOPOIETIC STEM CELL TRANSPLANTATION SURVIVORS: COMPARISON WITH A MATCHED REFERENCE COHORT.
por: van Yperen, Nicole, et al.
Publicado: (2023)

PB1795: BIO-INSPIRED NANOMEDICINE FOR TARGETED ACUTE MYELOID LEUKEMIA IMMUNOTHERAPY
por: Wang, X., et al.
Publicado: (2022)

PB1959: ESTABLISHMENT OF A NEW MULTIPLE MYELOMA (MM) RESEARCH MODEL USING MAGNETICALLY EMPOWERED TUMOR CELLS AND NK CELLS
por: Wang, Z., et al.
Publicado: (2022)

PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY：A SINGLE CENTER ANALYSIS IN THE REAL WORLD
por: LV, Mengnan, et al.
Publicado: (2023)

PB1941: PRELIMINARY EXPLORATION OF PROLONGED USE OF ELTROMBOPAG IN PATIENTS WITH NAÏVE SEVERE APLASTIC ANEMIA IN THE REAL WORLD: DURATION AND EFFICACY
por: Li, R., et al.
Publicado: (2022)

PB2417: PRESENCE´S IMPACT OF NON-SPECIFIC ANTI-HLA ANTIBODIES ON THE DEVELOPMENT OF PRIMARY GRAFT FAILURE IN PATIENTS UNDERGOING PERIPHERAL BLOOD HAPLOIDENTICAL HSCT, EXPERIENCE AT A CENTER IN MEXICO.
por: Daniel Garza Escobar, Juan, et al.
Publicado: (2023)

PB2014: TECLISTAMAB VS SELINEXOR-DEXAMETHASONE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING-ADJUSTED INDIRECT COMPARISON
por: Rosinol, L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vesmsk3s3m9cpg4mm3i4sls0hf